CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 34 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01199926
NCT01199926Phase 4Completed

Impact of Vitamin D Supplementation on Strength and Lean Mass Accumulation During an Exercise Intervention

Purdue University·interventional·Posted Sep 13, 2010·Updated May 15, 2015

In Brief

A Phase 4 clinical trial evaluating Vitamin D and Placebo for Obesity and 2 related conditions. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The study was designed to assess the effects of vitamin D supplementation during exercise training on body composition, muscle function, and glucose tolerance. The investigators hypothesis for these studies is that vitamin D supplementation enhances exercise-induced increases in strength and lean mass, potentially through enhancing insulin sensitivity and reducing inflammation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 13, 2010
Enrollment StartAug 1, 2008
Primary CompletionJul 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.8 years ago

Interventions

Vitamin Ddietary

4000 IU of vitamin D per day for 12 weeks.

Placebodrug

Placebo (microcrystalline cellulose) ingestion each day for 12 weeks.